Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up Study of Edwards Lifesciences INSPIRIS RESILIA Aortic Valve in Chinese Population

NCT05404880 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT05404880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05404880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up Study of Edwards Lifesciences INSPIRIS RESILIA Aortic Valve in Chinese Population
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Active, not recruiting
Start date
July 13, 2022
Completion date
December 31, 2034
Enrollment
255 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve replacement